SIGNAL-DRIVEN SALES

Turn Funding Signals into Pipeline

Fundz analyzes real-time funding events through YOUR lens to surface companies most likely to buy — with the “why now” built in.

10–25 ICP-matched leads daily • Buyer-intent scoring • No duplicates

Every plan includes:

✓Signal-Driven Leads Based on YOUR ICP

✓Slack + Chrome real-time alerts

✓No duplicates — only new events

INDUSTRY FIRST

Oncorus, Inc. announced it raised $53.8 Million in an amended filing from an offering of $89.6 Million

Dec 20, 2019•over 5 years ago

Amount Raised

$53.8 Million

CambridgeOther

Company News

(7 articles)

Mon, 12 Jun 2023 07:00:00 GMT

After layoffs leave Oncorus a 'shell' of a company, board liquidates the business - Fierce Biotech

Wed, 01 Aug 2018 07:00:00 GMT

Oncorus®, Inc., Names Industry Veteran Ted Ashburn as new President and CEO - PR Newswire

Fri, 02 Jun 2023 07:00:00 GMT

Facing bankruptcy, RNA-focused Oncorus lays off 'substantially' all its staff - Fierce Biotech

Wed, 14 Jun 2023 07:00:00 GMT

Biopharma layoff tracker 2023: Rejuvenate, GreenLight Biosciences, Oncorus and more cut staff - PharmaLive

Fri, 07 Oct 2022 07:00:00 GMT

Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer - Nature

Wed, 01 Aug 2018 07:00:00 GMT

Moderna's head of oncology leaves to helm new Cambridge cancer biotech Oncorus - The Business Journals

Fri, 09 Jun 2023 07:00:00 GMT

Chutes & Ladders—Oncorus sends 3 C-suite execs packing - Fierce Biotech

FundzWatch™ Score

Medium Activity

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech